ClinTex ICO Project Overview

-


What Is ClinTex?

ClinTex CTi is a distributed ledger platform technology targeted at the clinical trials market. The goal of this project is to provide end-to-end, decentralized solutions to improve the performance and quality of clinical trials: Insightful operational metrics Improved data review processes Machine learning and artificial intelligence Predictive data analytics, This platform will bring together clinical trial sponsors in a single space to provide access to information in real time and to share this knowledge faster and easier. This, in turn, will facilitate increased collaboration and significantly reduce the cost and time involved in developing and approving pharmaceuticals in an industry that is currently incredibly expensive and vast.

A problem that needs to be resolved. Most of the clinical trials are conducted by large pharmaceutical corporations that test the efficacy and safety of treatments and medicines to obtain regulatory approval for mass production.

There Are Four Main Phases Of Clinical Trials:
  • Testing in healthy volunteers
  • Testing on selected patients to view effectiveness and rate of success
  • Full-scale patient testing
  • Testing approved drugs to compare their effectiveness with alternatives
All stages of the clinical trial process are extremely labor intensive and the operating costs are astronomical. As nearly 650 million dollars astronomical. In addition, many of these clinical trials are not proactive but reactive. Ineffective voluntary patient recruitment and selection processes, as well as a complete lack of standardized data and inadequate administrative controls, are exhaustive and exacerbate some of the most serious problems inherent in the clinical trial system.

Interesting Solution ClinTex

The ClinTex project uses the dynamic Ethereum blockchain to create a project aimed at revolutionizing the drug market. They plan to achieve this through a combination of the public Ethereum blockchain, their own private blockchain (CTi), and a variety of useful decentralized applications, or DApps, each serving their own unique goal to enhance the project's functionality:
  • CTi OEM application.
  • Provide intuitive operational miscalculations in clinical trials for project managers, remote staff, and data management. This allows quick decision making to ensure successful research.
  • CTi-CDV application.
  • Provide advanced views of clinical data using imaging to identify areas of concern that could impact study integrity and patient safety. This application also handles problem flags and records and monitors corrective actions.
  • CTi-PDA application.
  • Combining clinical and real-time data sources for predictive modeling. Provides prediction of events and problems using artificial intelligence and machine learning algorithms. This app can reveal hidden correlations between data to facilitate proactive action.
  • Monitoring based on CTi risk.
  • Use historical and current data to predict risks, allowing you to plan your data and resource deployments to take preventive action. This approach differs significantly from modern reactive approaches and significantly reduces monitoring costs during clinical trials.
  • Patient acquisition / renewal.
  • This app provides a management platform for the retention and recruitment of patients and volunteers. This portal is intended for information, identification, and early warning noting when patients are at risk of study cancellation.

  • CTi Site Investigator Management.
  • Managing the recruitment of medical inspectors to manage and oversee clinical trials. This app also manages the company's token payments to these researchers, as determined by reference and metric triggers as defined on the platform.
  • CTi VMM application.
  • Supervision of data reliability and management of the company's token payments to third-party providers. They are also driven by milestone and metric triggers defined on the platform and by the clinical trial pharmaceutical company.

A Real Use Case For The ClinTex Concept.

The drug manufacturer and developer has conducted adequate studies of drug A, considering it as a solid counter-reactive drug for disease B. However, in a certain geographic region, disease B grows at an extremely fast rate, and the longer the waiting time (which averaged more than ten months in 2016) and the more expensive the pre-approval process for clinical trials, the more patients will end up contracting disease B, which can be fatal.

Thanks to the innovative and decentralized ClinTex platform, the pharmaceutical company that is part of Drug A will gain accelerated progress in the clinical trial chain, greater access to information and analysis to ensure accurate results, and incredible tools for predictive analysis and operational excellence.


ACCURATE INFORMATION

AUTHOR

Komentar

Posting Komentar

Postingan populer dari blog ini

The Suite ICO Review

-
Gambar
The Suite uses blockchain technology to decentralize the bonus card structure and is a new generation of blockchain loyalty program. The Suite uses blockchain technology to decentralize the structure of the Bonus cards and is a new generation of blockchain-based loyalty programs. The Suite  is a platform through which users can accumulate bonus points on one account, thereby simplifying the process of accumulating these points and there is no need to use a large number of Bonus cards.  On the platform, you can receive goods, request gift  cards of such basic online services (Amazon, Playstation, etc.), pay medical bills (national dentists). You can even make a request to exchange points for fiat money and transfer them to your bank account using a bank transfer. The basis of the project as a whole is the FidelitySuite platform . FidelitySuite  is a loyalty management platform that allows customers to collect and convert bonuses of partner companies registered on the p
Baca selengkapnya

Swan Finance is a decentralized financial world

-
Gambar
Decentralized Finance (DeFi) has proven to be an important part of cryptographic money, especially starting late. With ventures like UniSwap, Compound, and MakerDao, decentralized money has positioned itself more than the surface-level ICO disaster of 2017, centered on token deals and crowdfunding as opposed to certifiable and selfless development. DeFi has taken a big risk, no one can resist. The lending convention, the ability to trade, the self-governing exchange, all through the clever execution of treaties without permission. The DeFi 2020 venture has done an excellent job of expanding the lending area and acquiring and covering the significant barriers that are understood in the current crypto atmosphere, similar to the centralization of crypto trading. Staking is an approach to gaining interest in your crypto by approving exchanges on a public blockchain, and it is nothing new. Different cycles have existed since the beginnings of crypto. Think of mining, but without all the gea
Baca selengkapnya

Relam Investment launches Hetachain ICO based on 3rd Generation Blockchain technology

-
Gambar
Relam Investment has officially launched its 3rd generation blockchain technology ecosystem - Hetachain - and it's ICO. The global launch started in Dubai, and will proceed to London and Turkey throughout 2018. Hetachain is a super-fast DPoS + BFT hybrid blockchain network focused on addressing the age-long scalability dilemma and pushing forth a truly democratically governed platform built for industry scale transactions while also uniquely designed for private users. With its array of features integrating a blend of public and individual adoption-focused design through a multi-chain system, users can use Hetachain for both public and private blockchain preference. The Hetachain ecosystem consists of smart contracts, Hetacoin, hot and cold Heta Wallets, Heta App Store, Blockchain feature-enablers and comprehensive solutions that enhance its applicability in smart banking, healthcare, e-commerce, trade, telecommunications, data management, investment, cash exchange, and
Baca selengkapnya